In summary, these findings not only deepen our understanding of the role of TP73-AS1 in the mechanisms of HCC but also provide a theoretical basis for the future development of targeted therapeutic strategies against TP73-AS1 and its related molecular networks. This evidence concerns the gene TP73 and hepatocellular carcinoma.